Humana Inc HUM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if HUM is a good fit for your portfolio.
News
-
Humana Up Nearly 6%, on Pace for Largest Percent Increase Since September 2022 — Data Talk
-
Humana's stock falls as earnings outlook to remain unclear for months
-
UnitedHealth swings to a loss but stock surges after adjusted profit beats views
-
How a Biden-Trump rematch can keep healthcare ETFs afloat this election year
-
Why the CMS' Medicare Advantage rate is hurting stocks of Humana, UnitedHealth
-
Humana Down Nearly 13%, on Track for Lowest Close Since April 2020 — Data Talk
-
Cigna's stock leaps toward a 13-month high after earnings beat, raised dividend
-
Humana's stock falls to four-year low as company cuts 2024 guidance amid soaring medical costs
Trading Information
- Previous Close Price
- $324.20
- Day Range
- $332.20–332.20
- 52-Week Range
- —–584.80
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $40.03 Bil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- 15.12
- Price/Sales
- 0.41
- Dividend Yield (Trailing)
- 1.01%
- Dividend Yield (Forward)
- 0.99%
- Total Yield
- 6.04%
Company Profile
Humana is one of the largest private health insurers in the us with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Stock Style Box
- Mid Value
- Total Number of Employees
- 67,600
- Website
- https://www.humana.com
Competitors
Valuation
|
Metric
|
HUM
|
CVS
|
ELV
|
|---|---|---|---|
Price/Earnings (Normalized) | 15.12 | 7.67 | 15.60 |
Price/Book Value | 2.68 | 1.02 | 3.06 |
Price/Sales | 0.41 | 0.21 | 0.73 |
Price/Cash Flow | 12.94 | 6.34 | 13.80 |
Price/Earnings
HUM
CVS
ELV
Financial Strength
|
Metric
|
HUM
|
CVS
|
ELV
|
|---|---|---|---|
Quick Ratio | — | 0.54 | — |
Current Ratio | — | 0.81 | — |
Interest Coverage | 6.16 | 4.55 | 8.70 |
Quick Ratio
HUM
CVS
ELV
Profitability
|
Metric
|
HUM
|
CVS
|
ELV
|
|---|---|---|---|
Return on Assets (Normalized) | 4.42% | 4.07% | 7.36% |
Return on Equity (Normalized) | 14.12% | 13.68% | 20.87% |
Return on Invested Capital (Normalized) | 9.56% | 7.90% | 13.85% |
Return on Assets
HUM
CVS
ELV
Healthcare Plans Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc
UNH
| Sdpqjrqn | Nmvgnl | $457.5 Bil | |||
| Elevance Health Inc
ELV
| Nxjccvgkj | Xbtbdw | $124.3 Bil | |||
| The Cigna Group
CI
| Fsghhtvwm | Kvryh | $94.7 Bil | |||
| CVS Health Corp
CVS
| Gjjmwdyz | Hyvlz | $75.6 Bil | |||
| Humana Inc
HUM
| Lvpgsmty | Crsymc | $43.3 Bil | |||
| Centene Corp
CNC
| Wkkdsfjr | Fxgwkf | $36.8 Bil | |||
| Molina Healthcare Inc
MOH
| — | Hngkwg | $18.0 Bil | |||
| Oscar Health Inc Class A
OSCR
| — | Wpyw | $4.5 Bil | |||
| Alignment Healthcare Inc
ALHC
| — | Ngcfx | $1.6 Bil | |||
| Clover Health Investments Corp Ordinary Shares - Class A
CLOV
| — | Rqvxj | $541.1 Mil |